<p>A). Equal amounts of pNL4.3-GFP virus were used to infect vector-, HA-A3G-, or R88-A3G-transduced C8166 cell lines. After 48 hours of infection, virus-containing supernatants (passage 1) were collected, and the same volume of infectious supernatant was used to infect fresh and transduced C8166 cells (passage 2). The same procedure was performed again until virus-containing supernatants at assage 3 were obtained. Then, levels of HIV-1 Gag-p24 antigen in supernatants from passages 1, 2, and 3 were measured by HIV p24 ELISA assay. B). To test the effect of R88-A3G on virus infectivity, equal amounts (adjusted by Gag-p24 level) of virus from passage 1 were used to infect fresh R88-A3G-transduced C8166 cells. At different time points, the sup...
<p>(A) Transduction titers of VSV-G- or mNDK Env protein-pseudotyped HIV-1 vector on 293T, TE671, He...
<p>(<b>A</b>) To measure cell-free HIV-1 infections, we generated HIV-1<sub>GLuc</sub> by transfecti...
International audienceTo advance T cell-based HIV vaccine development, it is necessary to evaluate t...
<p>Viruses were produced from 293T cells transfected with 3 µg of HIV-1 HxBru-Vif<sup>+</sup> or HxB...
<p>Equal amounts of pNL4.3-GFP viruses produced from vector- or R88-A3G-transduced C8166 cells (in <...
(A) Experimental design. After 7 days of culture with AS1842856 (500nM) or vehicle only, PBT were in...
<p>Primary CD4 T cells from eight HIV positive or three HIV negative (data not shown) donors were tr...
<p>(A) Primary CD4 T cells were harvested, sorted into the resting subset, and stimulated with gp120...
<p>The relative level of viral replication in TZM-bl cells was measured following incubation with su...
<p>HEK293 cells grown in 96-well plates were co-transfected with 1 μg of each vector-driven siRNA (p...
<p>(A) Replication of HIV-1 in Huh7.5.1. Culture supernatants of RLuc and Jurkat T cells were collec...
<p>PBMCs were stained with anti-CD4, anti-CD45RA, anti-FOXP3, and anti-CCR5 or anti-CXCR4 antibodies...
<p><b>A.</b> p55/Gag-derived p24 levels in pseudovirus-producing HLtat cells. HIV(WT), HIV(W5A), HIV...
<p><b>(A)</b> Representative flow cytometry plots showing HIV infection in CFSE-low, vector-specific...
<p>Cells infected with NL4-3 virus were scored for p24 levels from culture supernatant after 48 hour...
<p>(A) Transduction titers of VSV-G- or mNDK Env protein-pseudotyped HIV-1 vector on 293T, TE671, He...
<p>(<b>A</b>) To measure cell-free HIV-1 infections, we generated HIV-1<sub>GLuc</sub> by transfecti...
International audienceTo advance T cell-based HIV vaccine development, it is necessary to evaluate t...
<p>Viruses were produced from 293T cells transfected with 3 µg of HIV-1 HxBru-Vif<sup>+</sup> or HxB...
<p>Equal amounts of pNL4.3-GFP viruses produced from vector- or R88-A3G-transduced C8166 cells (in <...
(A) Experimental design. After 7 days of culture with AS1842856 (500nM) or vehicle only, PBT were in...
<p>Primary CD4 T cells from eight HIV positive or three HIV negative (data not shown) donors were tr...
<p>(A) Primary CD4 T cells were harvested, sorted into the resting subset, and stimulated with gp120...
<p>The relative level of viral replication in TZM-bl cells was measured following incubation with su...
<p>HEK293 cells grown in 96-well plates were co-transfected with 1 μg of each vector-driven siRNA (p...
<p>(A) Replication of HIV-1 in Huh7.5.1. Culture supernatants of RLuc and Jurkat T cells were collec...
<p>PBMCs were stained with anti-CD4, anti-CD45RA, anti-FOXP3, and anti-CCR5 or anti-CXCR4 antibodies...
<p><b>A.</b> p55/Gag-derived p24 levels in pseudovirus-producing HLtat cells. HIV(WT), HIV(W5A), HIV...
<p><b>(A)</b> Representative flow cytometry plots showing HIV infection in CFSE-low, vector-specific...
<p>Cells infected with NL4-3 virus were scored for p24 levels from culture supernatant after 48 hour...
<p>(A) Transduction titers of VSV-G- or mNDK Env protein-pseudotyped HIV-1 vector on 293T, TE671, He...
<p>(<b>A</b>) To measure cell-free HIV-1 infections, we generated HIV-1<sub>GLuc</sub> by transfecti...
International audienceTo advance T cell-based HIV vaccine development, it is necessary to evaluate t...